Related Experiment Videos
Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain
W E Müller1, S Koch, K Scheuer
1Department of Psychopharmacology, Central Institute of Mental Health, Mannheim, Germany.
Abstract:
In vitro preincubation of brain membranes of aged mice with piracetam (0.1-1.0 mmol/L) enhanced membrane fluidity, as indicated by decreased anisotropy of the membrane-bound fluorescence probe 1,6-diphenyl-1,3,5-hexatriene (DPH). Piracetam had similar in vitro effects on brain membranes of aged rats and humans, but it did not alter brain membrane fluidity in young mice. Chronic treatment of young and aged rats with piracetam (300 mg/kg once daily) significantly increased membrane fluidity in some brain regions of the aged animals, but had no measurable effect on membrane fluidity in the young rats. The same treatment significantly improved active avoidance learning in the aged rats only. It is suggested that some of the pharmacological properties of piracetam can be explained by its effects on membrane fluidity.
Insights
Piracetam enhances brain membrane fluidity in aged animals, improving learning and memory. This effect was observed in vitro and after chronic treatment, suggesting a mechanism for piracetam
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Aging impacts brain membrane fluidity.
- Piracetam is a cognitive enhancer with an unclear mechanism of action.
Purpose of the Study:
- To investigate the effect of piracetam on brain membrane fluidity in aged animals.
- To explore the relationship between membrane fluidity and piracetam's cognitive effects.
Main Methods:
- In vitro incubation of brain membranes with piracetam.
- Measurement of membrane fluidity using the fluorescence probe 1,6-diphenyl-1,3,5-hexatriene (DPH).
- Chronic piracetam administration to young and aged rats, followed by behavioral testing (active avoidance learning).
Main Results:
- Piracetam (0.1-1.0 mmol/L) increased membrane fluidity in aged mice, rats, and human brain membranes in vitro.
- In vivo chronic treatment with piracetam significantly increased membrane fluidity in aged rats' brain regions.
- Piracetam treatment improved active avoidance learning in aged rats but not in young rats.
Conclusions:
- Piracetam's ability to enhance membrane fluidity may contribute to its pharmacological effects.
- The observed effects suggest that modulating membrane fluidity is a potential mechanism underlying piracetam's cognitive benefits in aging.